The International Dupuytren Award recognizes exceptional scientific publications on research or clinical treatment of Dupuytren and/or Ledderhose disease. Research can be about treatment, epidemiology, pathogenesis, genomics, or other areas, like anatomy, improving the understanding and treatment of these diseases.
The Award carries a monetary prize of 1,000 EUR.
The publication must be an original research paper that has been published in a peer reviewed journal or book and that has not yet been awarded elsewhere. The Award will normally be given to the leading (first) author but, upon request, the prize money can be split. Applicants can be physicians or scientists. Please submit only one paper per leading author, not several. We recommend to submit the paper that you consider presenting the most outstanding new research or clinical aspects.
The winner will be selected jointly by the Scientific Advisory Board and the Management Board of the International Dupuytren Society. The winner will be announced at the annual members‘ assembly of the Dupuytren Society or at another event selected by the Scientific Advisory Board. The International Dupuytren Award will be awarded annually but the Scientific Advisory Board may decide to waive the Award if the submitted publications for that year do not meet the criteria or do not score well enough when voted upon by the Board.
The award in a specific year is given for a paper that was published in the previous year. For example the Dupuytren Award 2010 was given for a publication of 2009.
Please submit applications for the 2025 Award (i.e. your paper published in 2024) latest by 31 March 2025 (deadline extended!), including
the submitted paper or at least its abstract should be in English. For submission in other languages please provide us with a translation.
Please email your application to
dupuytren_award /at / dupuytren-online . info (please adjust this email address).
The publication must be an original research paper that has been published in a peer reviewed journal or book and that has not yet been awarded elsewhere. The Award will normally be given to the leading (first) author but, upon request, the prize money can be split. Applicants can be physicians or scientists. Please submit only one paper per leading author, not several. We recommend to submit the paper that you consider presenting the most outstanding new research or clinical aspects.
Sponsor Institute/Organizations: International Dupuytren Society
Address: Westerbuchberg 60b 83236 Uebersee – Germany
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 31, 2025
Mar 31, 2025
$1,041
Affiliation: International Dupuytren Society
Address: Westerbuchberg 60b 83236 Uebersee – Germany
Website URL: https://www.dupuytren-online.info/dupuytren-award/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.